{"hands_on_practices": [{"introduction": "Our exploration of complement deficiencies begins with a common clinical scenario: interpreting foundational diagnostic tests. This first practice asks you to analyze the results from the *CH50* and *APH50* assays, the workhorse screening tools for the classical and alternative pathways, respectively. Successfully solving this problem requires understanding how these pathways differ and how their functional integrity is measured. [@problem_id:2224467]", "problem": "A 24-year-old patient presents with a history of recurrent pyogenic infections and a condition resembling systemic lupus erythematosus. An immunologist orders a panel to screen for complement system deficiencies. The results from two key functional assays are as follows:\n\n1.  **CH50 Assay:** This test, formally known as the Total Hemolytic Complement assay, measures the functional capacity of the classical complement pathway to lyse antibody-coated sheep red blood cells. The patient's CH50 value is zero.\n2.  **APH50 Assay:** This test, the Alternative Pathway Hemolytic assay, measures the functional capacity of the alternative complement pathway to lyse uncoated rabbit red blood cells. The patient's APH50 value is within the normal range.\n\nBased on these results, a deficiency in which of the following single complement proteins is the most likely cause of the patient's laboratory findings?\n\nA. Properdin\nB. $C3$\nC. $C4$\nD. $C9$\nE. Factor D", "solution": "The CH50 assay measures the integrity of the classical pathway leading to membrane attack complex (MAC) formation and hemolysis of antibody-coated sheep red blood cells. Functionally, this requires early classical components and the terminal cascade:\n- Classical pathway sequence: antigen-bound IgG/IgM activates C1 ($C1q$, $C1r$, $C1s$), which cleaves $C4$ and $C2$ to form the C3 convertase $C4b2a$, then $C3$ is cleaved to $C3b$, forming the C5 convertase and initiating MAC formation $C5b-C9$.\nThus, CH50 depends on {$C1q$, $C1r$, $C1s$, $C4$, $C2$, $C3$, $C5$, $C6$, $C7$, $C8$, $C9$}.\n\nThe APH50 assay measures the integrity of the alternative pathway, which proceeds independently of C1, C2, and C4:\n- Alternative pathway sequence: spontaneous C3 hydrolysis yields C3b, which binds factor B; factor D cleaves factor B to form the C3 convertase $C3bBb$, stabilized by properdin (P). This then activates C5 and drives MAC formation $C5b-C9$.\nThus, APH50 depends on {factor B, factor D, properdin, $C3$, $C5$, $C6$, $C7$, $C8$, $C9$}.\n\nGiven APH50 is normal, all proteins required for the alternative pathway are functionally intact, including the shared components $C3$ and $C5-C9$. Therefore, deficiencies in shared or alternative-specific proteins are excluded:\n- Excluded by normal APH50: $C3$ (choice B), $C9$ (choice D), properdin (choice A), and factor D (choice E).\n\nGiven CH50 is zero, there is a complete loss of classical pathway function, which must be due to a deficiency in a classical-specific component, since shared components are intact by the APH50 result. The classical-specific candidates are $C1q$, $C1r$, $C1s$, $C4$, or $C2$. Among the provided options, only $C4$ (choice C) is such a component.\n\nThe clinical history further supports an early classical pathway deficiency: deficiencies of $C1q$, $C2$, or $C4$ are classically associated with a lupus-like disease and increased susceptibility to pyogenic infections due to impaired clearance of immune complexes and opsonization.\n\nTherefore, the most likely single complement protein deficiency is $C4$.", "answer": "$$\\boxed{C}$$", "id": "2224467"}, {"introduction": "After an initial screen points to a defect in a shared part of the complement cascade, the diagnostic challenge is to pinpoint the exact protein at fault. This exercise simulates a set of reconstitution experiments, a classic immunological technique for identifying a specific missing component. Your task is to use the experimental outcomes to deduce a deficiency within the terminal Membrane Attack Complex, highlighting the logic of restoring a biological function by adding back a single purified element. [@problem_id:2224421]", "problem": "A patient presents with a history of recurrent, severe infections caused by *Neisseria* species. Suspecting an underlying immune system defect, an immunologist orders a series of tests on the patient's serum.\n\nThe first tests are functional assays for the complement system. A total classical complement activity assay (CH50), which measures the functional integrity of the $C1$ through $C9$ components, yields a result of nearly zero. Similarly, an alternative pathway assay (AH50) also shows virtually no activity. These results suggest a defect in the terminal pathway, specifically in the components that form the Membrane Attack Complex (MAC), the lytic pore-forming structure of the complement system.\n\nTo identify the specific faulty component, the immunologist performs a set of reconstitution experiments. In each experiment, the patient's serum is mixed with antibody-coated sheep red blood cells (the target for lysis) and a single, highly purified human complement protein. The mixtures are then observed for lytic activity. The results are as follows:\n\n-   **Experiment 1:** Patient serum + Purified $C8$ protein $\\rightarrow$ No cell lysis.\n-   **Experiment 2:** Patient serum + Purified $C9$ protein $\\rightarrow$ Normal cell lysis.\n-   **Experiment 3:** Patient serum + Purified $C3$ protein $\\rightarrow$ No cell lysis.\n\nBased on this complete set of laboratory findings, which of the following represents the most probable deficiency in this patient?\n\nA. $C3$ Deficiency\nB. $C8$ Deficiency\nC. $C9$ Deficiency\nD. Factor B Deficiency\nE. $C1q$ Deficiency", "solution": "Step 1: Interpret CH50 and AH50 results. The CH50 assay measures functional integrity of the classical pathway through formation of the Membrane Attack Complex (MAC), requiring components $C1$ through $C9$. The AH50 assay measures functional integrity of the alternative pathway, which also requires MAC formation. Near-zero CH50 and near-zero AH50 together indicate a defect in the common terminal pathway ($C5$ through $C9$), because defects restricted to early classical components (e.g., $C1q$) would reduce CH50 but not AH50, and defects restricted to the alternative pathway (e.g., Factor B) would reduce AH50 but not CH50.\n\nStep 2: Recall MAC assembly and its requirement for lysis. MAC is formed by sequential binding and insertion of complement components:\n$$\nC5 \\xrightarrow{\\text{C5 convertase}} C5b, \\quad C5b + C6 + C7 + C8 + n\\,C9 \\rightarrow \\text{MAC}.\n$$\nIn compact notation, the pore-forming complex can be written as $C5b6 \\cdot C7 \\cdot C8 \\cdot C9_{n}$.\n\nStep 3: Analyze the reconstitution experiments. In such assays, if adding a purified component restores lysis, that component is the missing factor; if lysis remains absent, either that component is not missing, or a different essential component remains absent.\n- Experiment 1: Patient serum + $C8$ yields no lysis. If $C8$ were deficient, adding $C8$ would restore lysis; lack of restoration indicates $C8$ is present and not the deficient component.\n- Experiment 2: Patient serum + $C9$ yields normal lysis. Restoration of lysis by adding $C9$ indicates that $C9$ is the deficient component, because all upstream components ($C5$ through $C8$) must be present and functional for $C9$ addition alone to complete MAC formation.\n- Experiment 3: Patient serum + $C3$ yields no lysis. If $C3$ were deficient, adding $C3$ should restore the formation of C5 convertase and hence MAC-mediated lysis in the classical assay with antibody-coated erythrocytes. The failure to restore lysis rules out $C3$ deficiency and is consistent with a terminal MAC defect such as $C9$ deficiency, because adding $C3$ cannot compensate for absence of $C9$.\n\nStep 4: Exclude other options using pathway logic.\n- $C3$ deficiency would reduce both CH50 and AH50 but would be expected to be corrected by $C3$ addition in this setup; Experiment 3 contradicts this.\n- $C8$ deficiency would be corrected by $C8$ addition; Experiment 1 contradicts this, while Experiment 2 supports $C9$ deficiency.\n- Factor B deficiency would selectively depress AH50 with relatively preserved CH50; both are near zero here, so this is unlikely.\n- $C1q$ deficiency would depress CH50 but leave AH50 near normal; this is not observed.\n\nConclusion: The data localize the defect to $C9$.\n\nTherefore, the most probable deficiency is $C9$ deficiency.", "answer": "$$\\boxed{C}$$", "id": "2224421"}, {"introduction": "The health of the complement system depends on a delicate balance between activation and inhibition. This final problem shifts our focus from deficiencies in pathway components to the failure of regulation. You will confront a case where severe $C3$ depletion is not caused by a faulty $C3$ protein itself, but by the absence of a key negative regulator, demonstrating how uncontrolled amplification can be as devastating as a lack of activation. [@problem_id:2224449]", "problem": "A two-year-old child is brought to a clinic with a history of recurrent, severe pyogenic (pus-forming) bacterial infections since infancy. A comprehensive immunological workup is performed. The results show a profoundly low level of serum Complement component 3 ($C3$), measuring less than 10% of the normal concentration. This finding suggests a high rate of $C3$ consumption. To investigate the root cause, genetic sequencing of the gene encoding $C3$ is performed, which reveals a completely normal, wild-type sequence, ruling out a primary defect in $C3$ production.\n\nThe central amplification loop of the complement system involves the C3 convertase, an enzyme complex that cleaves $C3$ into its active fragments. The activity of this convertase is normally under tight negative regulation to prevent systemic $C3$ depletion and host tissue damage. Given the patient's clinical and laboratory findings, a defect in a regulatory protein is suspected.\n\nBased on this information, a functional deficiency in which of the following proteins is the most probable cause of the patient's condition?\n\nA. Properdin (Factor P)\nB. Complement component $C5$\nC. Factor I\nD. Mannose-Binding Lectin (MBL)", "solution": "1. The child has recurrent severe pyogenic infections and profoundly low serum $C3$ with a normal $C3$ gene, which indicates excessive consumption rather than impaired synthesis of $C3$.\n\n2. The central amplification loop of the alternative pathway is driven by the alternative pathway C3 convertase, $C3bBb$, which cleaves $C3$:\n$$ \\text{C3} \\xrightarrow{\\text{C3 convertase}} \\text{C3a} + \\text{C3b} $$\nFormation and amplification proceed via:\n$$ C3b + B \\xrightarrow{D} C3bBb \\quad (\\text{alternative pathway C3 convertase}) $$\n\n3. Negative regulation that prevents runaway $C3$ consumption is primarily mediated by Factor I (a serine protease) acting with cofactors such as Factor H, MCP (CD46), and CR1, which inactivate $C3b$:\n$$ C3b \\xrightarrow{\\text{Factor I with Factor H/MCP/CR1}} iC3b $$\nBy cleaving $C3b$ to $iC3b$, Factor I terminates the amplification loop and protects against systemic $C3$ depletion.\n\n4. In Factor I deficiency, $C3b$ cannot be inactivated, leading to persistent formation and stabilization of $C3bBb$ and continuous cleavage of $C3$, thus markedly reducing serum $C3$ concentrations. Clinically, this causes recurrent pyogenic infections due to impaired opsonization.\n\n5. Evaluation of the options:\n- A. Properdin stabilizes $C3bBb$; deficiency would reduce alternative pathway activity and would not cause high $C3$ consumption. It classically predisposes to Neisseria infections with typically normal $C3$ levels.\n- B. $C5$ deficiency affects the terminal pathway and predisposes to Neisseria but does not cause systemic $C3$ consumption; $C3$ levels are usually normal.\n- C. Factor I deficiency removes the key negative regulator that inactivates $C3b$, causing uncontrolled C3 convertase activity and profound $C3$ depletionâ€”matching the findings.\n- D. MBL deficiency impairs lectin pathway initiation but does not drive unchecked $C3$ consumption; $C3$ levels are generally near normal.\n\n6. Therefore, the most probable cause is a functional deficiency of Factor I.", "answer": "$$\\boxed{C}$$", "id": "2224449"}]}